Two AstraZeneca breast cancer drugs get European Community Committee OK
Two AstraZeneca breast cancer drugs received positive recommendations for use in the European Union. AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been reco…